Newswise — Today, The Endocrine Society unveiled its newest journal, Hormones & Cancer. This bi-monthly journal will include research articles covering all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment.
Hormonal cancers include cancers of the breast and prostate, two of the most deadly cancer subtypes. Additional hormonal cancer subtypes to be addressed in Hormones & Cancer include thyroid, gynecologic and pituitary cancer. Bringing together endocrinology and oncology researchers, this new journal will span the multidisciplinary nature of this field of research by including basic scientific, epidemiological and translational research papers.
In collaboration with Springer Science + Business Media, The Endocrine Society has created an international editorial board that includes many of the leading experts in this interdisciplinary field of study. The editor-in-chief is Jonathan J. Li of the department of pharmacology, toxicology and therapeutics at Kansas University School of Medicine in Kansas City. Board members include V. Craig Jordan, the first scientist to discover the breast cancer prevention properties of tamoxifen, and Kathryn B. Horwitz, Distinguished Professor of Endocrinology, Metabolism and Diabetes at the University of Colorado Denver, and a past president of The Endocrine Society.
“The gap between endocrinology and oncology has existed for far too long and is clearly noticeable by the divisional structures we see in departments of medicine,” said Li. “The truth is that the relationship between cancer and hormones is important to researchers from multiple fields and it is our hope that Hormones & Cancer will help bring this group together to advance the medical community’s ability to understand and meet the needs of patients.”
“Hormones & Cancer is an exciting addition to The Endocrine Society’s growing family of scientific journals,” said Margaret Shupnik, the Society’s Publications Core Committee Chair. “Many of our members have a focus in this field, and they now have a research journal that fully explores the relationship between hormones, hormone-producing organs and cancer.”
Hormones & Cancer will be published bi-monthly, both electronically and in print. The first issue will be available online February 1st at http://www.springer.com/medicine/oncology/journal/12672.
Founded in 1916, The Endocrine Society is the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society’s membership consists of over 14,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied, and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at www.endo-society.org.